Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Apr 17;20(4):e0321988.
doi: 10.1371/journal.pone.0321988. eCollection 2025.

Impact of diabetes mellitus on 30-day mortality among acute stroke patients in northern Tanzania

Eugénie M Kamabu  1   2 , Justin L Paluku  3 , William P Howlett  1   4 , Abid M Sadiq  1   4 , Eliada B Nziku  1 , Doreen T Eliah  1   4 , Ibrahim Ali Ibrahim Muhina  1 , Fuad H Said  1 , Tumaini E Mirai  1   4 , Elifuraha W Mkwizu  1   4 , Furaha S Lyamuya  1   4 , Elichilia R Shao  1   4 , Kajiru G Kilonzo  1   4 , Venance P Maro  4 , Sarah J Urasa  1   4 , Nyasatu G Chamba  1   4
Affiliations

Impact of diabetes mellitus on 30-day mortality among acute stroke patients in northern Tanzania

Eugénie M Kamabu et al. PLoS One. .

Abstract

Background: Among acute stroke patients (ASPs), diabetes mellitus (DM) is associated with a higher risk of death, functional dependency, and recurrence. This study aimed to determine the impact of DM on the 30-day mortality among admitted ASPs in northern Tanzania.

Materials and methods: This was a hospital-based prospective cohort study performed among ASPs with and without DM who were admitted to Kilimanjaro Christian Medical Centre from November 2022 to May2023. ASPs were followed for 30 days after the onset of an acute stroke to identify the primary outcome, which was all-cause mortality. Descriptive statistics, logistic regression, and survival analysis were conducted.

Results: Out of 213 ASP, 82 (38.5%) had DM. The overall crude mortality rate was 46.9%. ASPs with DM had a higher mortality rate of 53.7% compared with those without DM (42.7%). A higher proportion of acute stroke patients with DM (84.1%) had a poor outcome (mRS 3-6) (p = 0.038). DM was statistically non-significant for 30-day mortality (aHR 1.56; 95% CI: 0.73-3.32; p = 0.252). However, fever (p = 0.005), severe admission Glasgow coma scale (p = 0.005), severe stroke (p = 0.008), elevated serum creatinine (p = 0.008), and an abnormal respiratory pattern (p = 0.042), were predictors of 30-day mortality.

Conclusion: This study demonstrated a high mortality in ASPs. Although DM did not have a significant impact on 30-day mortality, other factors, such as altered mental state, stroke severity, fever, elevated creatinine, and abnormal respiration, need to be accounted for that may have a significant impact on the mortality in ASPs. These findings highlight the significant burden of DM in stroke patients and underscore the importance of early diagnosis and treatment of ASPs, in the hopes of improving clinical practice and guidelines and reducing morbidity and mortality in Tanzania.

PubMed Disclaimer

Conflict of interest statement

The authors have declared that no competing interests exist.

Figures

Fig 1
Fig 1. Kaplan-Meier survival rate comparing patients with and without diabetes mellitus after acute stroke.
See this image and copyright information in PMC

References

    1. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Lernmark Å, et al.. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care. 2023;46(10):e151–99. doi: 10.2337/dci23-0036 - DOI - PMC - PubMed
    1. ElSayed NA, Aleppo G, Bannuru RR, Bruemmer D, Collins BS, Ekhlaspour L, et al.. 2. diagnosis and classification of diabetes: standards of care in diabetes—2024. Diabetes Care. 2024;47:S20–S42. doi: 10.2337/dc24-S002 - DOI - PMC - PubMed
    1. Feigin V, Norrving B, Sudlow CLM, Sacco RL. Updated criteria for population-based stroke and transient ischemic attack incidence studies for the 21st century. Stroke. 2018;49(9):2248–55. doi: 10.1161/STROKEAHA.118.022161 - DOI - PubMed
    1. Massi DG, Doumbe J, Patouokoumche RN, Ayeah CM, Kenmegne C, Mapoure YN. Outcome between diabetic versus non-diabetic acute stroke in a Black African population: a cohort study. WJNS. 2021;11(03):231–45. doi: 10.4236/wjns.2021.113017 - DOI
    1. Chen R, Ovbiagele B, Feng W. Diabetes and stroke: epidemiology, pathophysiology, pharmaceuticals and outcomes. Am J Med Sci. 2016;351(4):380–6. doi: 10.1016/j.amjms.2016.01.011 - DOI - PMC - PubMed